Ligand and Xoma are known as royalty aggregators that invest in drugs during development and collect royalties from their sales if the drugs succeed.
Source link
About The Author
Ligand Pharmaceuticals and Xoma Royalty, firms that collect drug royalties in exchange for helping fund development, are combining in a nearly $740 million deal, sources say